PARIS, October 28, 2016 /PRNewswire/ --
Sanofi, a global and diversified healthcare leader, reports results for thethird quarter of 2016. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on the results.
Watch video interview and read transcript:
- Q3 highlights
- Cost savings
- Capital allocation
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Subscribe to our Free Newsletters!
Statins are a group of drugs which help to lower the blood cholesterol levels.
Niemann-Pick disease is a group of inherited metabolic disorders in which cholesterol and lipids ...
Raspberries are packed with important nutrients, vitamins and minerals. They help boost immunity, ...View All